Form 6K Cybin Inc For: 5 January
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cybin Inc (HELP)
Cybin Inc stock price live, this page displays NLB HELP stock exchange data. View the HELP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cybin Inc real time stock price chart below.
What Is the Cybin Inc Stock Price Today?
The Cybin Inc stock price today is 8.15.
What Is the Stock Symbol for Cybin Inc?
The stock symbol for Cybin Inc is "HELP."
What Stock Exchange Does Cybin Inc Trade On?
Cybin Inc is listed and trades on the CBOE Canada stock exchange.
Is Cybin Inc a Good Stock to Buy?
Determining whether Cybin Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HELP quote. (ISIN: CA23256X4075)
What Is the Cybin Inc Stock Price Today?
The Cybin Inc stock price today is 8.15.
What Is the Stock Symbol for Cybin Inc?
The stock symbol for Cybin Inc is "HELP."
What Stock Exchange Does Cybin Inc Trade On?
Cybin Inc is listed and trades on the CBOE Canada stock exchange.
Is Cybin Inc a Good Stock to Buy?
Determining whether Cybin Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HELP quote. (ISIN: CA23256X4075)
8.11
-0.72(-8.15%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.10
8.90
52 wk Range
6.95
14.90
HELP is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.108.90
52 wk Range
6.9514.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HELP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
- Form 6K CYBIN INC. For: 31 December
- Investing.com
- Form 6K Cybin Inc For: 22 December
- Investing.com
- Form 6K CYBIN INC. For: 30 December
- Investing.com
- Form 6K Cybin Inc For: 5 January
- Investing.com
- Form 6K CYBIN INC. For: 31 December
- Investing.com
- Form 6K CYBIN INC. For: 30 December
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Cybin Inc Company Profile
Cybin Inc., doing business as Helus Pharma, a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company also develops SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat central nervous system, as well as has a research pipeline of investigational psychedelic-based compounds. It has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.
Compare HELP to Peers and Sector
Metrics to compare | HELP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHELPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.4x | −1.5x | −0.5x | |
PEG Ratio | −0.11 | 0.01 | 0.00 | |
Price/Book | 2.1x | 2.4x | 2.6x | |
Price / LTM Sales | - | 1.0x | 3.3x | |
Upside (Analyst Target) | - | 234.8% | 45.5% | |
Fair Value Upside | Unlock | −2.2% | 5.1% | Unlock |
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-1.39 / -0.05
Revenue / Forecast
-- / --
FAQ
What Is the Cybin (HELP) Stock Price Today?
The Cybin stock price today is 8.11
What Stock Exchange Does Cybin Trade On?
Cybin is listed and trades on the CBOE Canada Exchange.
What Is the Stock Symbol for Cybin?
The stock symbol for Cybin is "HELP."
What Is the Cybin Market Cap?
As of today, Cybin market cap is 441.38M.
What Is Cybin's Earnings Per Share (TTM)?
The Cybin EPS (TTM) is -5.52.
From a Technical Analysis Perspective, Is HELP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cybin Stock Split?
Cybin has split 2 times.
How Many Employees Does Cybin Have?
Cybin has 50 employees.
What is the current trading status of Cybin (HELP)?
As of Feb 13, 2026, Cybin (HELP) is trading at a price of 8.11, with a previous close of 8.83. The stock has fluctuated within a day range of 8.10 to 8.90, while its 52-week range spans from 6.95 to 14.90.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.